Adenoviral Vector Platform Development

About Batavia Biosciences

Batavia Biosciences is a specialized CDMO focused on viral vector and vaccine development and manufacturing, serving biotech and pharma clients globally. The company differentiates itself through proprietary technology platforms like HIP-Vax® and SCOUT, which aim to improve yields, reduce timelines, and lower costs in bioprocessing. With a strong track record of successful GMP runs and a high rate of returning customers, Batavia is positioned as a key partner in advancing novel biologics, particularly for infectious diseases and gene therapies. Its strategic partnerships, such as with VBC and MEVAC for vaccine localization in Africa, underscore its role in strengthening global health supply chains.

Therapeutic Areas